Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel-Reference-Cited by-同舟云学术

Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel

Published:2011-01 Issue:4 Volume:57 Page:399-408
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Morel Olivier,El Ghannudi Soraya,Jesel Laurence,Radulescu Bogdan,Meyer Nicolas,Wiesel Marie-Louise,Caillard Sophie,Campia Umberto,Moulin Bruno,Gachet Christian,Ohlmann Patrick

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Biology and pharmacology of the platelet P2Y12 receptor;Storey;Curr Pharm Des,2006

2. P2 receptors, platelet function and pharmacological implications;Gachet;Thromb Haemost,2008

3. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement;Hochholzer;J Am Coll Cardiol,2006

4. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome;Cuisset;J Thromb Haemost,2006

5. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up;Marcucci;Circulation,2009

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis;Kidney International Reports;2024-07

2. Editorial: Bleeding risk factors are also ischemic-event risk factors after percutaneous coronary intervention;Cardiovascular Revascularization Medicine;2024-02

3. Progress in the clinical effects and adverse reactions of ticagrelor;Thrombosis Journal;2024-01-10

4. Clopidogrel-Related High Residual Platelet Reactivity Associated with Estimated Glomerular Filtration Rate in Patients with Acute Ischemic Stroke;Cerebrovascular Diseases Extra;2023-10-09

5. The therapeutic potential of sphingolipids for cardiovascular diseases;Frontiers in Cardiovascular Medicine;2023-08-07